Lavaca Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Lavaca Capital's PFE Position: Q3 2026 in Review
Lavaca Capital increased its Pfizer (PFE) stake by 2.9% in Q3 2026, buying an estimated $8.3K and bringing the position to 11,185 shares worth $319K. The position accounts for 0.03% of the portfolio, ranked #107.
Lavaca Capital first reported a position in PFE in Q4 2018 and has held it in 32 quarters since. The position peaked at $2.44M in Q1 2021. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Lavaca Capital held 11,185 shares of Pfizer worth $319K as of Q3 2026.
- Lavaca Capital bought 312 Pfizer shares in Q3 2026, an estimated $8.3K.
- Pfizer made up 0.03% of Lavaca Capital's portfolio in Q3 2026, its #107 holding.
- Lavaca Capital first reported a position in Pfizer in Q4 2018 and has held it in 32 quarters since.
- Lavaca Capital's Pfizer position peaked at $2.44M in Q1 2021.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Lavaca Capital's 13F filing for Q3 2026, filed 16 Nov 2026.